Diabetes

A new study conducted by the digital chronic disease management company highlighted engagement behaviors associated with stronger outcomes over 12 months.

The company is looking to test the product in the U.S. and Europe, with the goal of gaining market approval for both regions by 2023. 

Movano's smartwatch-like wearable uses radio frequency technology to measure blood glucose without breaking the skin.

Members in 27 states and Washington D.C. are eligible to receive the Level2 chronic care model at no additional cost.

The system is able to continuously transmit glucose data every minute. 

From virtual management programs to hybrid closed loop systems, diabetes management companies put the spotlight on improved blood glucose management and positive clinical outcomes.

The study found that the flash continuous glucose monitoring system can cost about 60% less than traditional methods. 

Healthcare providers use a web interface to prescribe an initial dose "and BlueStar does the rest," according to Welldoc's chief medical officer.

Pharma giant Abbott led the round with participation from Quadrant Capital Advisors Senvest Capital, Janus Henderson, Cormorant Asset Management and other funders. 

A new study suggests that a deep learning system would save on the roughly two minutes of human labor required to grade each case, although a semi-automated approach was found to drive the greatest savings for large programs.